Fujifilm Corp. and Dr. Reddy’s Laboratories have signed a Memorandum of Understanding (MoU) to establish a joint venture to develop, manufacture and promote generic drugs in Japan. Fujifilm will hold a 51% stake and Dr. Reddy’s will have the remainder. The JV will utilize Fujifilm’s quality control technologies and Dr. Reddy’s expertise in cost competitive production technologies for APIs and formulations. The JV plans to launch its first products in Japan in the next three to four years,...